SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

GROENHUYSEN WILHELMUS CM

(Last)

(First)

(Middle)

C/O NOVOCURE INC., 20 VALLEY STREAM PKWY

SUITE 300

(Street)

MALVERN

19355

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
10/01/2015

3. Issuer Name and Ticker or Trading Symbol
Novocure Ltd [ NVCR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	263,128	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options to Buy Ordinary Shares	⁽¹⁾	12/14/2021	Ordinary Shares	523,732	$3.44	D
Options to Buy Ordinary Shares	⁽²⁾	02/20/2023	Ordinary Shares	88,695	$7.03	D
Options to Buy Ordinary Shares	⁽³⁾	02/26/2024	Ordinary Shares	59,130	$7.48	D
Options to Buy Ordinary Shares	⁽⁴⁾	02/25/2025	Ordinary Shares	266,085	$14.37	D

Explanation of Responses:

1. Options to buy 327,017 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 196,715 ordinary shares will vest and become exercisable on January 1, 2016, subject to Mr. Groenhuysen's continued employment through such date.

2. Options to buy 44,347 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 44,348 ordinary shares will vest and become exercisable in equal installments on February 20, 2016 and 2017, subject to Mr. Groenhuysen's continued employment through such dates.

3. Options to buy 14,782 ordinary shares are vested and currently exercisable as of the date hereof. The remaining options to buy 44,348 ordinary shares will vest and become exercisable in equal installments on each of February 26, 2016, 2017 and 2018, subject to Mr. Groenhuysen's continued employment through such dates.

4. The options to buy 266,085 ordinary shares will vest and become exercisable in equal installments on each of the first four anniversaries of February 25, 2015, subject to Mr. Groenhuysen's continued employment through such dates.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Todd Longsworth, Attorney in fact for Wilhelmus Groenhuysen	10/01/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.